Background Scleroderma (SSc) is an autoimmune connective tissue disease progressing with fibrosis. SSc patients need to be protected from epidemic diseases as well as rehabilitation needs. For this reason, it is important for them to continue their exercises in an environment where they can be both rehabilitated and protected from infectious diseases.

Objectives In this study, it was aimed to reveal the effects of exercises performed by telerehabilitation on individuals with Scleroderma with hand involvement and to compare the effects of real-time telerehabilitation (RTT) and asynchronous telerehabilitation (AT).

Methods Forty-two participants with a mean age of 44.17±11.05 years were included in the study. The patients were divided into three groups and followed for 8 weeks. RTT was applied to the 1st group and AT was applied to the 2nd group, and the 3rd group was the control group. Participants’ finger and wrist joint range of motion (ROM) were evaluated with a goniometer, upper extremity functions were evaluated with Scleroderma Hand Mobility Test (HAMIS), Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and 9Hole Peg Test (9HPT), grip strength was evaluated with a dynamometer, superficial sense of touch was evaluated with the Semmes Weinstein Monofilament test, activities of daily living (ADL) were evaluated with the Michigan Hand Outcomes Questionnaire (MHQ), and general health status was evaluated with the Scleroderma Health Assessment Questionnaire (SHAQ).

Results There were improvements in finger and wrist ROM, upper extremity functions and ADL parameters in the RTT group; and there were improvement in finger ROM and hand functions in the AT group (p<0.05). Wrist radial deviation ROM decreased in the control group (p<0.05). Significant differences were noted between the groups in finger ROM and upper extremity functions after treatment (p<0.05).

Conclusion Our study shows that exercises performed via RTT and AT are effective in individuals with Scleroderma with hand involvement, and RTT has additional benefits.

References [1]Sendur N, Sendur UG. Scleroderma. Turkiye Klinikleri J Dermatol. 2018;15-20.

[2]Baron M, Lee P, Keystone EC. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis. 1982;41(2):147-152.

[3]Spinella A, Magnani L, De Pinto M, et al. Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2021; 15:1–3.

[4]Smith AC, Thomas E, Snoswell CL, et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare 2020;26(5):309-313.

Disclosure of Interests None declared